Cholinesterase inhibitors improve cognitive outcomes in such patients, but the benefits of these drugs for behavioral disturbances are unclear.
胆碱酯酶抑制剂可改善此类患者的认知功能,但这种药物对于行为障碍的疗效并未肯定。
Previous trials of DHA supplementation have had significant limitations and yielded mixed results, for both postpartum depressive symptoms and cognitive outcomes in the children.
而以前有关DHA补充剂的试验具有显明的局限性,在产后抑郁症和婴幼儿的认知结果两方面产生了混淆的结果。
应用推荐